This website uses cookies and, in some cases, third-party cookies, to improve user experience. By clicking the button or continuing to use the website you agree to the use of cookies. To find out more, including how to change your settings, see our Cookie Policy.

Verastem Oncology 5.00% 2048-11 USD

New bond issue: Verastem Oncology (NASDAQ:VSTM) issued new debt notes (US92337CAA27, 92337CAA2) for 150M USD as of October 12, 2018. Tradable at TRACE OTC as of October 12, 2018.

Verastem Oncology (VSTM) is an American biopharmaceutical company focused on development of medicines to improve the lives of patients diagnosed with cancer. It is headquartered in Needham, Massachusetts, United States.

IssuerVerastem Oncology
Stock (Group)NASDAQ:VSTM
Bond TypeCorporate
CategorySenior, Convertible, Callable, SEC Registered
Maturity DateNovember 1, 2048
Residual Duration29 years, 15 days
CurrencyUSD (United States Dollar)
Coupon TypeFixed Rate
Coupon (Yearly)5.000%
Coupon FrequencySemiannual
Minimum Lot1,000 USD
Additional Lots1,000 USD
Issue DateOctober 17, 2018
Issued Amount150,000,000 USD
Issue Price100.000%
Maturity Price100.000%
Conversion Terms7.16 USD 15%
Home ExchangeTRACE
IsinUS92337CAA27
Cusip92337CAA2
Issue DocumentationIssue Prospectus
IndustryBiotechnology
SectorHealth Care
CountryUnited States
RegionAmerica developed


Bonds, Corporate, Health Care, Biotechnology, America developed, United States, USD, Fixed Rate, Income


Next Fire BC FLR% 2024-09 EUR

investopoli.com